Global Market News
FDA Should Mandate NDAs Include Trial Data on Women: JAMA
The FDA should turn away device applications that don’t include sufficient clinical trial data on women in order to encourage devicemakers to study possible gender differences in their products, a recent Journal of the American Medical Association (JAMA) article concludes.
For more information, click here.
Return to Previous Page